Contemporary OB/GYN week in review: vulvovaginal candidiasis, monoclonal antibodies, and more

News
Article

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Contemporary OB/GYN week in review: vulvovaginal candidiasis, monoclonal antibodies, and more

Contemporary OB/GYN week in review: vulvovaginal candidiasis, monoclonal antibodies, and more

Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, January 29 - Friday, February 2, 2024), and click each link to read and watch anything you may have missed.

1.) Oteseconazole outperforms fluconazole in treating severe vulvovaginal candidiasis

A phase 3 trial demonstrated that oteseconazole (VIVJOA; Mycovia Pharmaceuticals) capsules exhibit improved therapeutic and mycological cure rates to fluconazole for treating severe vulvovaginal candidiasis.

Click here for the full article.

2.) How monoclonal antibodies revolutionize sexual health

Explore the potential of monoclonal antibodies for contraception and sexually transmitted infection prevention, providing a comprehensive review of their safety, efficacy, and pharmacokinetics.

Click here for the full article.

3.) Two-dose HPV vaccination postpartum shows efficacy

A recent study revealed a 2-dose regimen of human papillomavirus vaccination in postpartum individuals is as effective as a 3-dose approach, providing valuable insights into optimizing vaccination strategies against the virus.

Click here for the full article.

4.) The Guardians app shows efficacy for reducing perinatal depression

Preliminary findings suggest The Guardians mobile app, blending gaming and behavioral activation techniques, could be a solution for alleviating perinatal depression among pregnant women.

Click here for the full article.

5.) Dexmedetomidine found effective for reducing postpartum depression risk

A recent study revealed that early postpartum administration of dexmedetomidine significantly reduces the risk of postpartum depression among women with prenatal depression.

Click here for the full article.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Zachary Wagner, PhD, discusses the harms of bias in reproductive care | Image Credit: ornsife.usc.edu.
Ciera Kirkpatrick, PhD, shows how TikTok is transforming cervical cancer awareness | Image Credit: linkedin.com.
Maria Gallo, PhD, discusses high attendance at crisis pregnancy centers | Image Credit: © x.com.
Veerle Bergink, MD, PhD, highlights familial links of postpartum psychosis | Image Credit: profiles.mountsinai.org.
Lisa Bayer, MD, MPH
Megan Cohen, MD, MPH, outlines 2024 CDC contraception guidelines | Image Credit: linkedin.com.
Tia Welsh, MD, highlights breakthroughs in cervical cancer screening | Image Credit: doctors.valleyhealth.com.
Laxmi Gannu, MD, notes PPD screening gaps and adverse outcomes | Image Credit: linkedin.com.
Elizabeth Mollard, PhD, WHNP, CNM
Victoria Wang, MD, discusses surveillance for high-grade dysplasia | Image Credit: account.allinahealth.org.
Related Content
© 2025 MJH Life Sciences

All rights reserved.